BBSE3
ONconsolidatedBB SEGURIDADE PARTICIPAÇÕES S.A.
CNPJ 17344597000194
—
Ratios
Q3 25 → Q2 26Share capital from the FRE dated 2026-12-31. The FRE is annual — buybacks and issuances after that date are not reflected here.
computed — The CVM does not publish Q4 on its own — the annual filing carries the full year. This figure is the year minus the first nine months.
Distributions
| Type | Approved on | Ex-date basis | R$ / share |
|---|---|---|---|
| DIVIDENDO | 2026-06-24 | 2026-08-06 | 1.983285 |
| DIVIDENDO | 2025-12-17 | 2026-02-12 | 2.549965 |
| RENDIMENTO | 2025-12-17 | 2026-02-12 | 0.056842 |
| DIVIDENDO | 2025-06-27 | 2025-08-14 | 1.942095 |
| DIVIDENDO | 2024-12-20 | 2025-02-20 | 2.272329 |
| RENDIMENTO | 2024-12-20 | 2025-02-20 | 0.047832 |
| DIVIDENDO | 2024-06-21 | 2024-08-16 | 1.390909 |
| DIVIDENDO | 2023-12-15 | 2024-02-08 | 1.241876 |
| RENDIMENTO | 2023-12-15 | 2024-02-08 | 0.019413 |
| DIVIDENDO | 2023-06-30 | 2023-08-16 | 1.607637 |
| DIVIDENDO | 2022-12-16 | 2023-02-14 | 1.839874 |
| RENDIMENTO | 2022-12-16 | 2023-02-14 | 0.038704 |
Gross amounts, by record date, from B3's registry — the Type column separates dividends, interest on equity and capital returns, and the 12-month yield adds all of them. A capital return is a refund, not income. Interest on equity (JCP) carries 15% withholding tax for individuals — the net yield is lower. Payment dates are not in this registry; they live in the shareholder notice.
Ratios by year
| Year | Revenue | Net income | Gross margin | Net margin | ROE | ROA | Turnover | Year-end price | P/E | DY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0.00 | 9.02bn | — | — | 86.8% | 39.0% | — | 36.15 | 7.77 | 11.8% |
| 2024 | 0.00 | 8.70bn | — | — | 89.8% | 40.3% | — | 36.18 | 8.11 | 7.3% |
| 2023 | 0.00 | 7.95bn | — | — | 81.0% | 43.5% | — | 33.65 | 8.43 | 10.4% |
| 2022 | 0.00 | 6.04bn | — | — | 79.6% | 37.5% | — | 33.71 | 11.14 | 5.8% |
| 2021 | 0.00 | 3.93bn | — | — | 54.0% | 29.5% | — | 20.75 | 10.53 | 4.8% |
| 2020 | 0.00 | 3.85bn | — | — | 60.3% | 35.3% | — | 29.63 | 15.36 | 14.0% |
| 2019 | 0.00 | 6.66bn | — | — | 126.9% | 44.6% | — | 37.70 | 11.30 | 4.2% |
| 2018 | 0.00 | 3.54bn | — | — | 51.8% | 25.9% | — | 27.59 | 15.56 | 11.2% |
| 2017 | 0.00 | 4.05bn | — | — | 45.5% | 30.4% | — | 28.49 | 14.05 | 5.8% |
| 2016 | 0.00 | 4.01bn | — | — | 48.4% | 32.0% | — | 28.30 | 14.08 | 5.9% |
| 2015 | 0.00 | 4.21bn | — | — | 55.5% | 36.6% | — | 24.33 | 11.56 | 6.9% |
| 2014 | 0.00 | 3.46bn | — | — | 43.6% | 33.3% | — | 32.16 | 18.61 | 3.7% |
| 2013 | 0.00 | 2.47bn | — | — | 35.6% | 28.2% | — | 24.50 | 19.81 | 1.7% |
From each fiscal year's DFP, with the close of the fiscal year-end month alongside. Yearly P/E and DY use the fiscal year-end close against that year's EPS and payouts — both already per share. An empty cell carries its reason in the tooltip: a loss, EPS out of scale, lot-of-a-thousand quoting, a split in the way. Yearly P/B is left out: it would need that year's share count, and the registration filing stores the latest approval's count under the reference date.
Quarterly results
| Period | Revenue | Operating | Net income | Net margin |
|---|---|---|---|---|
| Q2 26 | 0.00 | 1.11bn | 2.41bn | — |
| Q1 26 | 0.00 | 1.21bn | 2.14bn | — |
| Q4 25 | 0.00 | 1.32bn | 2.30bn | — |
| Q3 25 | 0.00 | 1.20bn | 2.33bn | — |
| Q2 25 | 0.00 | 1.15bn | 2.42bn | — |
| Q1 25 | 0.00 | 1.20bn | 1.96bn | — |
| Q4 24 | 0.00 | 1.36bn | 2.29bn | — |
| Q3 24 | 0.00 | 1.16bn | 2.25bn | — |
| Q2 24 | 0.00 | 1.08bn | 2.14bn | — |
| Q1 24 | 0.00 | 1.14bn | 2.02bn | — |
| Q4 23 | 0.00 | 1.25bn | 2.10bn | — |
| Q3 23 | 0.00 | 1.05bn | 2.12bn | — |
Balance sheet
| Period | Total assets | Equity | Assets / Equity | Current ratio |
|---|---|---|---|---|
| Q2 26 | 21.92bn | 10.89bn | 2.01 | 1.15 |
| Q1 26 | 19.62bn | 12.64bn | 1.55 | 2.45 |
| Q4 25 | 23.10bn | 10.38bn | 2.22 | 1.28 |
| Q3 25 | 20.44bn | 12.87bn | 1.59 | 2.35 |
| Q2 25 | 21.38bn | 10.49bn | 2.04 | 1.40 |
| Q1 25 | 18.52bn | 11.66bn | 1.59 | 2.50 |
| Q4 24 | 21.62bn | 9.70bn | 2.23 | 1.20 |
| Q3 24 | 19.21bn | 12.25bn | 1.57 | 2.17 |
| Q2 24 | 19.02bn | 10.06bn | 1.89 | 0.97 |
| Q1 24 | 17.85bn | 12.02bn | 1.49 | 1.73 |
| Q4 23 | 18.27bn | 9.82bn | 1.86 | 1.08 |
| Q3 23 | 16.24bn | 10.66bn | 1.52 | 1.61 |
A balance sheet is a snapshot, not a window: there is no “computed Q4” here — December's figure is what the annual filing published.
What the company filed
| Filing | Period | Filed on | Days after close | Document |
|---|---|---|---|---|
| ITRT2 | 2026-06-30 | 2026-08-03 | 34 | CVM ↗ |
| ITRT1 | 2026-03-31 | 2026-05-04 | 34 | CVM ↗ |
| DFPanual | 2025-12-31 | 2026-02-09 | 40 | CVM ↗ |
| ITRT3 | 2025-09-30 | 2025-11-03 | 34 | CVM ↗ |
| ITRT2 | 2025-06-30 | 2025-08-04 | 35 | CVM ↗ |
| ITRT1 | 2025-03-31 | 2025-05-05 | 35 | CVM ↗ |
| DFPanual | 2024-12-31 | 2025-02-17 | 48 | CVM ↗ |
| ITRT3 | 2024-09-30 | 2024-11-04 | 35 | CVM ↗ |
| ITRT2 | 2024-06-30 | 2024-08-05 | 36 | CVM ↗ |
| ITRT1 | 2024-03-31 | 2024-05-06 | 36 | CVM ↗ |
| DFPanual | 2023-12-31 | 2024-02-05 | 36 | CVM ↗ |
| ITRT3 | 2023-09-30 | 2023-11-06 | 37 | CVM ↗ |
| ITRT2 | 2023-06-30 | 2023-08-07 | 38 | CVM ↗ |
| ITRT1 | 2023-03-31 | 2023-05-15 | 45 | CVM ↗ |
| DFPanual | 2022-12-31 | 2023-02-09 | 40 | CVM ↗ |
| ITRT3 | 2022-09-30 | 2022-11-07 | 38 | CVM ↗ |
When the next one is due
This is measured habit, not company guidance: the CVM publishes no forward calendar as open data. The estimate applies this company's historical median to the next period.